Analogues of 1-O-hexadecyl-sn-3-glycerophosphonocholine (compounds 1-4) or sn-3-glycerophosphocholine (compound 5) bearing a
carbamate or dicarbamate moiety at the sn-2 position were synthesized and evaluated for their antiproliferative activity against
cancer cells derived from a variety of tissues. Although all of the compounds are antiproliferative, surprisingly the
carbamates (1 and 2) are more effective against the
hormone-independent cell lines DU145 and PC3 than toward other
cancer cell lines we examined. This selectivity was not observed with the dicarbamates (3 and 4).
Phosphocholine carbamate analogue 5 is as effective against the
prostate cancer cell lines as the corresponding phosphonocholine analogue 1. Cell death induced by 2'-(trimethylammonio)ethyl 4-hexadecyloxy-3(R)-N-methylcarbamoyl-1-butanephosphonate (
carbamate analogue 2) appeared to be mediated by apoptosis, as assessed by
caspase activation and loss of mitochondrial membrane potential. The in vivo activity of 2 was evaluated in a murine
prostate cancer xenograft model. Oral and
intravenous administration showed that 2 is effective in inhibiting the growth of PC3
tumors in Rag2M mice. Our studies show that the glycerolipid
carbamates reported herein represent a class of
prostate-cancer-selective
cytotoxic agents.